INSULIN-LIKE GROWTH FACTOR-1 (IGF-1): RELATION WITH COGNITIVE FUNCTIONING AND NEUROIMAGING MARKER OF BRAIN DAMAGE IN A SAMPLE OF HYPERTENSIVE ELDERLY SUBJECTS

被引:32
作者
Angelini, A. [1 ]
Bendini, C. [1 ]
Neviani, F. [1 ]
Bergamini, L. [1 ]
Manni, B. [1 ]
Trenti, T. [2 ]
Rovati, R. [3 ]
Neri, M. [1 ]
机构
[1] Modena & Reggio Emilia Univ, Dept Geriatr, NOCSAE Nuovo Osped Civile S Agostino Estense, I-41100 Baggiovara, MO, Italy
[2] Univ Parma, Dept Psychol, Parma, PR, Italy
[3] NOCSAE Nuovo Osped Civile S Agostino Estense, Dept Neuroradiol, I-41100 Baggiovara, MO, Italy
关键词
Insulin-like growth factor-1 (IGF-1); Alzheimer's disease; cognitive decline; hypertensive elderly subjects; Cambridge cognitive examination (CAMDEX-R); frontal assessment battery (FAB); MESSENGER-RNA; SERUM-LEVELS; EXERCISE; EXPRESSION; INSULIN-LIKE-GROWTH-FACTOR-1; PROTEINS; HEALTH;
D O I
10.1016/j.archger.2009.09.006
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
IGF-1 decline has been related to age-dependent cognitive impairment and dementia. No study examined IGF-1 levels in subjects with a risk factor for brain damage such as hypertension. We investigated the relationship between IGF-1, cognitive functioning and neuroimaging in a sample of 75 hypertensive elderly subjects aged > 65. Cognitive performance were tested by mini mental state examination (MMSE), Cambridge cognitive examination (CAMDEX-R), and the frontal assessment battery (FAB). Among other indices, free IGF-1 in serum was assayed. The radial width of the temporal horn (rWTH) evaluates medial cerebral temporal lobe atrophy. Significant correlations between IGF-1 levels and both total and sub-domain scores of cognition were found. IGF-1 level was significantly lower in cognitively declined group. The lowest IGF-1-percentile subgroup was significantly cognitively impaired. A statistically non-significant, but lower IGF-1 level was found in the sub-sample with pathologically wider rWTH. Levels of IGF-1 below 79.4 mu g/I are associated with cognitive decline, whereas a level above 118 mu g/I seems to be a marker of normal cognitive performance. A decreasing of IGF-1 related to a widening of the rWTH suggests an involvement of this hormone in hippocampus atrophy.
引用
收藏
页码:5 / 12
页数:8
相关论文
共 37 条
[1]   Insulin-like growth factor-I and cognitive function in healthy older men [J].
Aleman, A ;
Verhaar, HJJ ;
De Haan, EHF ;
De Vries, WR ;
Samson, MM ;
Drent, ML ;
Van der Veen, EA ;
Koppeschaar, HPF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :471-475
[2]   INSULIN-LIKE GROWTH FACTOR-I (SOMATOMEDIN-C) RECEPTORS IN THE RAT-BRAIN - DISTRIBUTION AND INTERACTION WITH THE HIPPOCAMPAL CHOLINERGIC SYSTEM [J].
ARAUJO, DM ;
LAPCHAK, PA ;
COLLIER, B ;
CHABOT, JG ;
QUIRION, R .
BRAIN RESEARCH, 1989, 484 (1-2) :130-138
[3]   The relation between insulin-like growth factor I levels and cognition in healthy elderly: A meta-analysis [J].
Arwert, LI ;
Deijen, JB ;
Drent, ML .
GROWTH HORMONE & IGF RESEARCH, 2005, 15 (06) :416-422
[4]  
Barde Y A, 1994, Prog Clin Biol Res, V390, P45
[5]   Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus [J].
Berchtold, NC ;
Kesslak, JP ;
Pike, CJ ;
Adlard, PA ;
Cotman, CW .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2001, 14 (12) :1992-2002
[6]   Signaling by insulin-like growth factor 1 in brain [J].
Bondy, CA ;
Cheng, CM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 490 (1-3) :25-31
[7]   The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease [J].
Carro, E ;
Torres-Aleman, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 490 (1-3) :127-133
[8]   Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy [J].
Carro, E ;
Trejo, JL ;
Busiguina, S ;
Torres-Aleman, I .
JOURNAL OF NEUROSCIENCE, 2001, 21 (15) :5678-5684
[9]   Serum insulin-like growth factor I regulates brain amyloid-levels [J].
Carro, E ;
Trejo, JL ;
Gomez-Isla, T ;
LeRoith, D ;
Torres-Aleman, I .
NATURE MEDICINE, 2002, 8 (12) :1390-1397
[10]  
CARRO E, 2004, EXPERT REV NEUROTHER, V4, P78